John M. Lachin
George Washington University
1 paper in the Anchorcite directory, published in 2015, cited 12,596 times in total.
ORCID profileResearch topics
- Diabetes, Cardiovascular Risks, and Lipoproteins · 1 paper
- Diabetes Treatment and Management · 1 paper
- Heart Failure Treatment and Management · 1 paper
Frequent co-authors
- Bernard Zinman · 1 paper
- Christoph Wanner · 1 paper
- DAVID H. FITCHETT · 1 paper
- Erich Bluhmki · 1 paper
- Stefan Hantel · 1 paper
- Michaela Mattheus · 1 paper
- Theresa Devins · 1 paper
- Odd Erik Johansen · 1 paper
Papers
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesNew England Journal of Medicine · 2015 · 12,596 citations
BACKGROUND: The effects of empagliflozin, an inhibitor of sodium-glucose cotransporter 2, in addition to standard care, on cardiovascular morbidity and mortality in patients with type 2 diabetes at high cardiovascular risk are not known. METHODS: We randomly assigned patients to…
Metadata from OpenAlex (CC0).